Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Epithelial TRAF6 drives IL-17–mediated psoriatic inflammation
Reiko Matsumoto, Teruki Dainichi, Soken Tsuchiya, Takashi Nomura, Akihiko Kitoh, Matthew S. Hayden, Ken J. Ishii, Mayuri Tanaka, Tetsuya Honda, Gyohei Egawa, Atsushi Otsuka, Saeko Nakajima, Kenji Sakurai, Yuri Nakano, Takashi Kobayashi, Yukihiko Sugimoto, Kenji Kabashima
Reiko Matsumoto, Teruki Dainichi, Soken Tsuchiya, Takashi Nomura, Akihiko Kitoh, Matthew S. Hayden, Ken J. Ishii, Mayuri Tanaka, Tetsuya Honda, Gyohei Egawa, Atsushi Otsuka, Saeko Nakajima, Kenji Sakurai, Yuri Nakano, Takashi Kobayashi, Yukihiko Sugimoto, Kenji Kabashima
View: Text | PDF
Research Article Dermatology Immunology

Epithelial TRAF6 drives IL-17–mediated psoriatic inflammation

  • Text
  • PDF
Abstract

Epithelial cells are the first line of defense against external dangers, and contribute to induction of adaptive immunity including Th17 responses. However, it is unclear whether specific epithelial signaling pathways are essential for the development of robust IL-17–mediated immune responses. In mice, the development of psoriatic inflammation induced by imiquimod required keratinocyte TRAF6. Conditional deletion of TRAF6 in keratinocytes abrogated dendritic cell activation, IL-23 production, and IL-17 production by γδ T cells at the imiquimod-treated sites. In contrast, hapten-induced contact hypersensitivity and papain-induced IgE production were not affected by loss of TRAF6. Loss of psoriatic inflammation was not solely due to defective imiquimod sensing, as subcutaneous administration of IL-23 restored IL-17 production but did not reconstitute psoriatic pathology in the mutant animals. Thus, TRAF6 was required for the full development of IL-17–mediated inflammation. Therefore, epithelial TRAF6 signaling plays an essential role in both triggering and propagating IL-17–mediated psoriatic inflammation.

Authors

Reiko Matsumoto, Teruki Dainichi, Soken Tsuchiya, Takashi Nomura, Akihiko Kitoh, Matthew S. Hayden, Ken J. Ishii, Mayuri Tanaka, Tetsuya Honda, Gyohei Egawa, Atsushi Otsuka, Saeko Nakajima, Kenji Sakurai, Yuri Nakano, Takashi Kobayashi, Yukihiko Sugimoto, Kenji Kabashima

×

Figure 2

IL-17–mediated gene expression was impaired in Traf6EKO mice.

Options: View larger image (or click on image) Download as PowerPoint
IL-17–mediated gene expression was impaired in Traf6EKO mice.
(A) Heatma...
(A) Heatmap of differentially expressed genes in Traf6EKO mice and Traf6fl/fl mice with or without IMQ treatment. Genes differentially expressed more than 2-fold by IMQ treatment in either mouse group (674 genes) were analyzed. Representative psoriasis-related genes are indicated. (B) Scatter plots of gene expression in Traf6EKO mice and Traf6fl/fl mice. Left panel shows correlation of gene expression between IMQ-treated Traf6EKO mice and IMQ-treated Traf6fl/fl mice. Right panel shows correlation between fold changes in gene expression induced by IMQ treatment in Traf6EKO mice and in Traf6fl/fl mice. Representative psoriasis-related genes are indicated by red plots accompanied with their names. (C) Pathways enriched in genes upregulated by IMQ treatment in Traf6fl/fl mice compared with Traf6EKO mice. Pathways with P < 0.05 are shown. (D) qPCR analysis of mRNA levels in the epidermis of the IMQ-treated mouse ears on day 2 (n ≥ 3). The results were normalized to Gapdh expression and are shown as means ± SD. *P < 0.05 (Tukey’s multiple-comparisons test). Data are representative of 3 experiments (D) or 1 experiment (A–C).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts